If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 101 - 110 of 309
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticoste
Objective
Lebrikizumab vs. Placebo w/ Steroids in CRSwNP
Protocol No
OTO-ELILILLY-J2T-MC-KGBU
Categories
A Phase Ib Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients with Relapsed/Refractory Multiple Myeloma
Objective
Study of talquetamab in patients with R/R multiple myeloma
Protocol No
IIT-AKHTAR-CILTA-TALQ
Categories
A Modular Phase II, Single-Arm, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of AZD0486 in Participants with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (SOUNDTRACK-B)
Objective
We are doing this study to learn more about the experimental treatment AZD0486, to learn if the study drug will be safe, tolerable and effective in treating the type of lymphoma that you have.
Protocol No
AZ-D7404C00001-SOUNDTRACK-B
Categories
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial
Objective
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Protocol No
SURG-NHLBI-LEADER-PAD
A Phase 3, Open-Label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) (IDeate-Prostate01)
Objective
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer
Protocol No
MERCK-MK-2400-001
Categories
MitoQ (Mitoquinol Mesylate) to Ameliorate Vascular Function in Preeclampsia: a Novel Approach
Objective
MitoQ to Improve Vascular Funciton in Preeclampsia
Protocol No
OBG-IIT-MCINTOSH-MAVEN
Categories
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
Objective
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Protocol No
ALLIANCE-A032302-ASPIRE
Categories
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Objective
Evaluation of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
Protocol No
PULM-MEDIAR-MTX-463-I201
Categories
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
Objective
Psycho-Spiritual Management for Patients with Advanced Cancer and Family Caregivers
Protocol No
MDACC-2023-0450
A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, PK, and Efficacy of MK-1084 as Monotherapy and as Part of Various Combination Therapies in Subjects with KRAS G12C Mutant Advanced Solid Tumors
Objective
This project is being done to test the safety and tolerability of MK-1084 alone in combination with pembrolizumab in patients with solid tumor cancers that have a mutated KRAS gene.
Protocol No
MERCK-MK1084-001
Categories
Cancer,
Kidney,
Other Skin,
Thoracic Cancers,
Sarcoma,
Gastrointestinal Cancers,
Cervix,
Prostate and Urologic Cancers,
Other Gynecologic,
Breast Cancers,
Ovary,
Gynecologic Cancers,
Head and Neck Cancers,
Early Phase/Multiple Disease Site Cancers,
Endocrine Cancers,
Melanoma, Skin,
Eye/Orbital Cancers,
Skin Cancers